ALUXIVA Trademark

Trademark Overview


On Tuesday, January 15, 2008, a trademark application was filed for ALUXIVA with the United States Patent and Trademark Office. The USPTO has given the ALUXIVA trademark a serial number of 77372331. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 13, 2009. This trademark is owned by Glaxo Group Limited. The ALUXIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
aluxiva

General Information


Serial Number77372331
Word MarkALUXIVA
Filing DateTuesday, January 15, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 13, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events


Event DateEvent Description
Monday, April 13, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 13, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, September 11, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 11, 2008FINAL REFUSAL E-MAILED
Thursday, September 11, 2008FINAL REFUSAL WRITTEN
Thursday, August 21, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 21, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 21, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 25, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 25, 2008NON-FINAL ACTION E-MAILED
Friday, April 25, 2008NON-FINAL ACTION WRITTEN
Monday, April 21, 2008ASSIGNED TO EXAMINER
Friday, January 18, 2008NEW APPLICATION ENTERED IN TRAM